Drug
KW 6500
KW 6500: highest development phase Phase 3, developed by Kyowa Kirin. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| KW-6500 NCT01058291 | Phase 3 | Parkinson's Disease |
| KW-6500 NCT01063621 | Phase 3 | Parkinson's Disease |
Latest
No recent events.
Follow KW 6500 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.